https://doi.org/10.1016/j.jacc.2021.10.028
S
Sicong Ma
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
22
Papers
230
Citations
7
h-index
6
i10-index
Sicong Ma is an academic researcher from Shanghai University of Traditional Chinese Medicine. The author has contributed to research in topics: Antiplatelet Therapy and Cardiovascular Diseases & Coronary Interventions and Diagnostics & Acute Myocardial Infarction Research. The author has an h-index of 7, co-authored 19 publications.
ORCID: 0000-0002-2233-9967Papers by this author
worksMagnetically Controlled Capsule Endoscopy for Assessment of Antiplatelet Therapy–Induced Gastrointestinal Injury
2021 · Journal of the American College of Cardiology · 69 citations
Antiplatelet effect, safety, and pharmacokinetics of vicagrel in patients with coronary artery disease undergoing percutaneous coronary intervention
2022 · European Heart Journal - Cardiovascular Pharmacotherapy · 17 citations
https://doi.org/10.1093/ehjcvp/pvac026
Fibroblast growth factor 21 and prognosis of patients with cardiovascular disease: A meta-analysis
2023 · Frontiers in Endocrinology · 9 citations
https://doi.org/10.3389/fendo.2023.1108234
Comparison of the efficacy and safety of ticagrelor and clopidogrel in patients with acute coronary syndrome after risk stratification
2021 · Catheterization and Cardiovascular Interventions · 4 citations
https://doi.org/10.1002/ccd.29591
Predictors and long‐term outcomes of in‐hospital switching from clopidogrel to ticagrelor among patients with acute coronary syndrome undergoing percutaneous coronary intervention
2022 · Catheterization and Cardiovascular Interventions · 0 citations
https://doi.org/10.1002/ccd.30089
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat